substance., Treprostinil clinical trials

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON-2)

This study is looking at a new inhaled medicine, treprostinil, for people with Idiopathic Pulmonary Fibrosis (IPF). Researchers want to see if it helps improve lung function and overall health compared to a dummy medicine. It's a large study involving many people.